Korean clinical practice guideline for benign prostatic hyperplasia
In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medicine and the Korean Continence Society to develop a...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Urological Association
2016-01-01
|
Series: | Investigative and Clinical Urology |
Subjects: | |
Online Access: | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-57-30.pdf |
_version_ | 1811261642429693952 |
---|---|
author | Jeong Kyun Yeo Hun Choi Jae Hyun Bae Jae Heon Kim Seong Ok Yang Chul Young Oh Young Sam Cho Kyoung Woo Kim Hyung Ji Kim |
author_facet | Jeong Kyun Yeo Hun Choi Jae Hyun Bae Jae Heon Kim Seong Ok Yang Chul Young Oh Young Sam Cho Kyoung Woo Kim Hyung Ji Kim |
author_sort | Jeong Kyun Yeo |
collection | DOAJ |
description | In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed
of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medicine and
the Korean Continence Society to develop a Korean clinical practice guideline for BPH. The purpose of this clinical practice guideline is to provide current and comprehensive recommendations for the evaluation and treatment of BPH. The committee developed the guideline mainly by adapting existing guidelines and partially by using the de novo method. A comprehensive literature review was carried out primarily from 2009 to 2013 by using medical search engines including data from Korea. Based on the published evidence, recommendations were synthesized, and the level of evidence of the recommendations was determined by using methods adapted from the 2011 Oxford Centre for Evidence-Based Medicine. Meta-analysis was done for one key question and four recommendations. A draft guideline was reviewed by expert peer reviewers and discussed at an expert consensus meeting
until final agreement was achieved. This evidence-based guideline for BPH provides recommendations to primary practitioners and urologists for the diagnosis and treatment of BPH in men older than 40 years. |
first_indexed | 2024-04-12T19:08:20Z |
format | Article |
id | doaj.art-b5932369b0f14206bb88126128f9e43d |
institution | Directory Open Access Journal |
issn | 2466-0493 2466-054X |
language | English |
last_indexed | 2024-04-12T19:08:20Z |
publishDate | 2016-01-01 |
publisher | Korean Urological Association |
record_format | Article |
series | Investigative and Clinical Urology |
spelling | doaj.art-b5932369b0f14206bb88126128f9e43d2022-12-22T03:19:58ZengKorean Urological AssociationInvestigative and Clinical Urology2466-04932466-054X2016-01-01571304410.4111/icu.2016.57.1.30 Korean clinical practice guideline for benign prostatic hyperplasiaJeong Kyun Yeo0Hun Choi1Jae Hyun Bae2Jae Heon Kim3Seong Ok Yang4Chul Young Oh5Young Sam Cho6Kyoung Woo Kim7Hyung Ji Kim8Inje University College of MedicineKorea University College of MedicineKorea University College of MedicineSoonchunhyang University College of MedicineVHS Medical CenterHallym University College of MedicineSungkyunkwan University College of MedicineInje University College of MedicineDankook University College of MedicineIn 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medicine and the Korean Continence Society to develop a Korean clinical practice guideline for BPH. The purpose of this clinical practice guideline is to provide current and comprehensive recommendations for the evaluation and treatment of BPH. The committee developed the guideline mainly by adapting existing guidelines and partially by using the de novo method. A comprehensive literature review was carried out primarily from 2009 to 2013 by using medical search engines including data from Korea. Based on the published evidence, recommendations were synthesized, and the level of evidence of the recommendations was determined by using methods adapted from the 2011 Oxford Centre for Evidence-Based Medicine. Meta-analysis was done for one key question and four recommendations. A draft guideline was reviewed by expert peer reviewers and discussed at an expert consensus meeting until final agreement was achieved. This evidence-based guideline for BPH provides recommendations to primary practitioners and urologists for the diagnosis and treatment of BPH in men older than 40 years.https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-57-30.pdfGuideline; Lower urinary tract symptoms; Prostate; Prostatic hyperplasia |
spellingShingle | Jeong Kyun Yeo Hun Choi Jae Hyun Bae Jae Heon Kim Seong Ok Yang Chul Young Oh Young Sam Cho Kyoung Woo Kim Hyung Ji Kim Korean clinical practice guideline for benign prostatic hyperplasia Investigative and Clinical Urology Guideline; Lower urinary tract symptoms; Prostate; Prostatic hyperplasia |
title | Korean clinical practice guideline for benign prostatic hyperplasia |
title_full | Korean clinical practice guideline for benign prostatic hyperplasia |
title_fullStr | Korean clinical practice guideline for benign prostatic hyperplasia |
title_full_unstemmed | Korean clinical practice guideline for benign prostatic hyperplasia |
title_short | Korean clinical practice guideline for benign prostatic hyperplasia |
title_sort | korean clinical practice guideline for benign prostatic hyperplasia |
topic | Guideline; Lower urinary tract symptoms; Prostate; Prostatic hyperplasia |
url | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-57-30.pdf |
work_keys_str_mv | AT jeongkyunyeo koreanclinicalpracticeguidelineforbenignprostatichyperplasia AT hunchoi koreanclinicalpracticeguidelineforbenignprostatichyperplasia AT jaehyunbae koreanclinicalpracticeguidelineforbenignprostatichyperplasia AT jaeheonkim koreanclinicalpracticeguidelineforbenignprostatichyperplasia AT seongokyang koreanclinicalpracticeguidelineforbenignprostatichyperplasia AT chulyoungoh koreanclinicalpracticeguidelineforbenignprostatichyperplasia AT youngsamcho koreanclinicalpracticeguidelineforbenignprostatichyperplasia AT kyoungwookim koreanclinicalpracticeguidelineforbenignprostatichyperplasia AT hyungjikim koreanclinicalpracticeguidelineforbenignprostatichyperplasia |